Qianjiang Yongan Pharmaceutical Co.,Ltd.’s Net Profit Dropped 48.8% in First Half of 2023

Qianjiang Yongan Pharmaceutical Co.,Ltd. (潜江永安药业股份有限公司) (002365.SZ) reported a net profit of 57 million yuan in the first half of 2023, down 48.8% year-on-year.

Meanwhile, the company posted 578.4 million yuan in revenue, down 30% year-on-year.

At the end of the reporting period, it had 2.5 billion yuan in total assets and 314.8 million yuan in total liabilities, with a liability-to-asset ratio of 12.8%.